The last day of operation for Hertfordshire and West Essex ICB was 31 March 2026. The information on this website has not been updated since 31 March 2026. The legacy policies, prescribing recommendations and pathways can be accessed on this website. Find out more

Find clinical documents

or

Document type:
RAG rating:question mark
Place:
Output type:
Medicine / Guideline Indication RAG rating Document type Place
Abrocitinib Atopic dermatitis - moderate severe Red NICE technology appraisal Hertfordshire and West Essex ICB
Acitretin Psoriasis, ichthyosis, Darier's disease Red Decision document Hertfordshire and West Essex ICB
Actinic keratosis Actinic keratosis n/a Prescribing pathway Hertfordshire and West Essex ICB
Adalimumab Psoriasis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB
Alitretinoin Eczema - hand severe Red NICE technology appraisal Hertfordshire and West Essex ICB
Apremilast Psoriasis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB
Aveeno switch patient letter Emollient Double Red Primary Care prescribing resource Hertfordshire and West Essex ICB
Back Pain n/a Clinical pathways East and North Hertfordshire
Baricitinib Alopecia areata Double Red NICE technology appraisal Hertfordshire and West Essex ICB
Baricitinib Atopic dermatitis - moderate severe Red NICE technology appraisal Hertfordshire and West Essex ICB
Bath and shower preparations Dry and pruritic skin conditions Double Red Prescribing guideline Hertfordshire and West Essex ICB
Bimekizumab Psoriasis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB
Biologic and Biosimilar Medicines Where indicated n/a Patient information Hertfordshire and West Essex ICB
Botulinum toxin type A Focal spasticity, Hemi-facial spasm, Blepharospasm, Cervical dystonia, Frey’s syndrome, Chronic anal fissure, Dysphagia, Hirschsprung’s disease, Overactive bladder,Masseteric hypertrophy and temporomandibular disorders Red Prescribing guideline Hertfordshire and West Essex ICB
Brodalumab Psoriasis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB
Certoliziumab Psoriasis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB
Chalazia (meibomian cysts) removal n/a Clinical policy Hertfordshire and West Essex ICB
Chalazia Prior Approval Form n/a Prior approval form Hertfordshire and West Essex ICB
Chlormethine gel Mycosis fungoides-type cutaneous T-cell lymphoma (NHSE) Red NICE technology appraisal Hertfordshire and West Essex ICB
Clascoterone Acne Vulgaris Double Red NICE technology appraisal Hertfordshire and West Essex ICB
Delgocitinib Chronic Hand Eczema Red NICE technology appraisal Hertfordshire and West Essex ICB
Dermatology / Skin Lesions / Skin Health for Adults over 16 years old n/a Clinical pathways Hertfordshire and West Essex ICB
Deucravacitinib Psoriasis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB
Diclofenac sodium 3% gel Actinic keratosis Green Prescribing guideline Hertfordshire and West Essex ICB
Dimethyl fumarate Psoriasis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB
Dupilumab Prurigo Nodularis Double Red NICE technology appraisal Hertfordshire and West Essex ICB
Dupilumab Atopic dermatitis - moderate severe Red NICE technology appraisal Hertfordshire and West Essex ICB
Emollient Guidelines Topical Use n/a Decision document Hertfordshire and West Essex ICB
Emollients Topical Use n/a Patient information Hertfordshire and West Essex ICB
Etanercept Psoriasis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB
Fluorouracil 0.5% / Salicylic acid 10% cutaneous solution Actinic keratosis Green Prescribing guideline Hertfordshire and West Essex ICB
Fungal Nail Management n/a Clinical pathways Hertfordshire and West Essex ICB
Glycopyrronium bromide Hyperhidrosis Double Red Decision document Hertfordshire and West Essex ICB
Guselkumab Psoriasis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB
Hyperhidrosis n/a Clinical policy Hertfordshire and West Essex ICB
Hyperhidrosis Hyperhidrosis - self help n/a Patient information Hertfordshire and West Essex ICB
Hyperhidrosis Management n/a Clinical pathways Hertfordshire and West Essex ICB
Imiquimod 3.75% cream Actinic keratosis Double Red Prescribing guideline Hertfordshire and West Essex ICB
Imiquimod 5% cream Actinic keratosis Red Prescribing guideline Hertfordshire and West Essex ICB
Infliximab IV Psoriasis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB
Isotretinoin Acne Red n/a Hertfordshire and West Essex ICB
Ivermectin 10mg/ml cream Papulopustular rosacea Green Decision document Hertfordshire and West Essex ICB
Ixekizumab Psoriasis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB
Lebrikizumab Atopic dermatitis - moderate to severe Red NICE technology appraisal Hertfordshire and West Essex ICB
Mepacrine (unlicensed medicine) Subacute cutaneous and Discoid lupus erythematosus Red n/a Hertfordshire and West Essex ICB
Methoxsalen Cancer, psoriasis Red n/a Hertfordshire and West Essex ICB
Minocycline Acne Double Red Prescribing guideline Hertfordshire and West Essex ICB
Minocycline Patient information leaflet Acne n/a Patient information Hertfordshire and West Essex ICB
Nemolizumab Atopic dermatitis - moderate severe Red NICE technology appraisal Hertfordshire and West Essex ICB
Omalizumab Urticaria - severe chronic Red NICE technology appraisal Hertfordshire and West Essex ICB
Pigmanorm Melasma Double Red Decision document Hertfordshire and West Essex ICB
Plastics Referral Pathway (including scar revision) n/a Patient information Hertfordshire and West Essex ICB
Prednisolone All indications - soluble tablet n/a Patient information Hertfordshire and West Essex ICB
Prednisolone enteric coated All indications Double Red n/a Hertfordshire and West Essex ICB
Promethazine All indications n/a Position statement Hertfordshire and West Essex ICB
Psoriasis Psoriasis - severe localised Red Decision document Hertfordshire and West Essex ICB
Psoriasis Psoriasis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB
Psoriasis Topical Treatment - Adults n/a Clinical pathways Hertfordshire and West Essex ICB
Risankizumab Psoriasis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB
Ritlecitinib Alopecia Areata - Severe Red Decision document Hertfordshire and West Essex ICB
Ruxolitinib cream Non-segmental vitiligo Double Red NICE technology appraisal Hertfordshire and West Essex ICB
Scar Revision n/a Clinical policy Hertfordshire and West Essex ICB
Scar Revision Prior Approval Form n/a Prior approval form Hertfordshire and West Essex ICB
Secukinumab Psoriasis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB
Silk Garments Eczema dermatitis n/a Patient information Hertfordshire and West Essex ICB
Silk garments Eczema dermatitis Double Red Prescribing guideline Hertfordshire and West Essex ICB
Skin Cancer Suspected - Pigmented Lesion/ Melanoma/ SCC/ BCC n/a Patient information Hertfordshire and West Essex ICB
Spesolimab Psoriasis - Pustular flares Red NICE technology appraisal Hertfordshire and West Essex ICB
Sunscreens Protection against UV radiation (ACBS) Green Decision document Hertfordshire and West Essex ICB
Sunscreens Protection against UV radiation (ACBS) Green Prescribing guideline Hertfordshire and West Essex ICB
Surgical Removal of Benign Skin Lesions n/a Clinical policy Hertfordshire and West Essex ICB
Surgical Removal of Benign Skin Lesions Prior Approval Form n/a Prior approval form Hertfordshire and West Essex ICB
Tildrakizumab Psoriasis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB
Tirbanibulin Actinic keratosis Green Prescribing guideline Hertfordshire and West Essex ICB
Tralokinumab Atopic dermatitis - moderate severe Red NICE technology appraisal Hertfordshire and West Essex ICB
Upadacitinib Atopic dermatitis - moderate severe Red NICE technology appraisal Hertfordshire and West Essex ICB
Ustekinumab Psoriasis - moderate severe Red Prescribing pathway Hertfordshire and West Essex ICB